5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 27.74▼ | 27.82▼ | 27.78▼ | 29.06▼ | 28.48▼ |
MA10 | 27.83▼ | 27.83▼ | 27.82▼ | 28.99▼ | 29.41▼ |
MA20 | 27.88▼ | 27.83▼ | 28.29▼ | 28.58▼ | 33.16▼ |
MA50 | 27.78▼ | 28.91▼ | 29.09▼ | 29.87▼ | 37.18▼ |
MA100 | 27.84▼ | 28.94▼ | 28.61▼ | 33.60▼ | 34.58▼ |
MA200 | 29.00▼ | 28.47▼ | 29.21▼ | 36.49▼ | 36.52▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.041▼ | 0.057▲ | -0.024▼ | 0.018▲ | -0.483▼ |
RSI | 37.294▼ | 36.753▼ | 33.317▼ | 40.379▼ | 31.838▼ |
STOCH | 20.833 | 54.082 | 33.503 | 62.415 | 24.980 |
WILL %R | -100.000▼ | -98.980▼ | -99.281▼ | -70.427 | -87.570▼ |
CCI | -203.603▼ | -129.996▼ | -206.003▼ | -84.870 | -72.805 |
CDL | $SRDX Engulfing Candlestick Pattern Detected | Set Alert |
Thursday, May 01, 2025 09:46 AM
Despite the strength in Pounce thrombectomy device platforms and strong IVD product sales, Surmodics' second-quarter fiscal 2025 results show weak performance.
|
Wednesday, April 30, 2025 11:06 AM
Surmodics is "working diligently" in response to the FTC’s lawsuit seeking to block its $627 million sale to GTCR, CEO Gary Maharaj said.
|
Wednesday, April 30, 2025 07:00 AM
For the quarter ended March 2025, SurModics (SRDX) reported revenue of $28.09 million, down 12.1% over the same period last year. EPS came in at -$0.13, compared to $0.07 in the year-ago quarter.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 27.93 | 28.045 | 27.56 | 27.56 | 19,150 |
01/05/25 | 27.71 | 28.17 | 27.46 | 27.86 | 66,496 |
30/04/25 | 27.85 | 28.6903 | 26.00 | 28.01 | 245,721 |
29/04/25 | 30.965 | 31.09 | 30.37 | 30.76 | 78,833 |
28/04/25 | 29.41 | 31.275 | 29.06 | 31.10 | 88,078 |
25/04/25 | 29.09 | 29.52 | 27.925 | 29.46 | 50,560 |
24/04/25 | 28.55 | 29.80 | 28.54 | 29.40 | 94,700 |
23/04/25 | 28.87 | 29.62 | 28.3604 | 28.60 | 40,547 |
22/04/25 | 28.61 | 28.97 | 28.04 | 28.61 | 60,539 |
21/04/25 | 27.37 | 28.72 | 27.02 | 28.55 | 113,180 |
|
|
||||
|
|
||||
|
|